• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非囊性纤维化支气管扩张症患者发病和死亡的风险因素:回顾性横断面分析 CT 诊断的支气管扩张症患者。

Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients.

机构信息

Laboratory of Pneumology, Katholieke Universiteit Leuven, Leuven, Belgium.

出版信息

Respir Res. 2012 Mar 16;13(1):21. doi: 10.1186/1465-9921-13-21.

DOI:10.1186/1465-9921-13-21
PMID:22423975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3379934/
Abstract

INTRODUCTION

There is a relative lack of information about the death rate and morbidity of non-cystic fibrosis bronchiectasis and most studies are limited due to referral bias. We wanted to assess death rate and morbidity in those patients at our hospital.

METHODS

Adult patients seen at our department between June 2006 and November 2009 were recruited if the key string "bronchiect-" was mentioned in electronic clinical records and if chest CT imaging was available. Clinical records of all patients with confirmed radiologic diagnosis of bronchiectasis were reviewed and clinical characteristics were analyzed.

RESULTS

539 patients with a radiographic diagnosis of non-cystic fibrosis bronchiectasis were identified in a retrospective cross-sectional analysis giving a prevalence of 2.6% in our hospital population. A wide range of etiologies was found with idiopathic bronchiectasis in 26%. In the 41 months interval, 57 patients (10.6%) died. We found a median exacerbation rate of 1.94 per year. Bacterial colonization status was associated with more deaths, exacerbation rate, symptoms and reduced pulmonary function. Pulmonary hypertension was found in 48% of our patients.

CONCLUSIONS

We evaluated a large non-cystic fibrosis bronchiectasis population, and provided new epidemiological data on associations between clinical characteristics and deaths and morbidity in these patients.

摘要

介绍

非囊性纤维化性支气管扩张症的死亡率和发病率相关信息相对较少,且大多数研究因转诊偏倚而受限。我们希望评估我院此类患者的死亡率和发病率。

方法

如果电子病历中提到关键字符串“bronchiect-”,并且有胸部 CT 成像,则招募 2006 年 6 月至 2009 年 11 月在我院就诊的成年患者。对所有经影像学诊断为支气管扩张症的患者的临床记录进行了回顾,并分析了临床特征。

结果

在回顾性横断面分析中,539 例患者被诊断为非囊性纤维化性支气管扩张症,在我院人群中的患病率为 2.6%。病因广泛,特发性支气管扩张症占 26%。在 41 个月的间隔内,有 57 例(10.6%)患者死亡。我们发现每年的平均恶化率为 1.94 次。细菌定植状态与更多的死亡、恶化率、症状和降低的肺功能有关。我们的患者中有 48%患有肺动脉高压。

结论

我们评估了一个大型非囊性纤维化性支气管扩张症患者人群,并提供了这些患者的临床特征与死亡和发病率之间关联的新的流行病学数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/a445fbe8b0f8/1465-9921-13-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/846f12d15f41/1465-9921-13-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/ebd3fe382a01/1465-9921-13-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/a445fbe8b0f8/1465-9921-13-21-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/846f12d15f41/1465-9921-13-21-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/ebd3fe382a01/1465-9921-13-21-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd5/3379934/a445fbe8b0f8/1465-9921-13-21-3.jpg

相似文献

1
Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients.非囊性纤维化支气管扩张症患者发病和死亡的风险因素:回顾性横断面分析 CT 诊断的支气管扩张症患者。
Respir Res. 2012 Mar 16;13(1):21. doi: 10.1186/1465-9921-13-21.
2
Pulmonary hypertension in patients with bronchiectasis: prognostic significance of CT signs.支气管扩张症患者的肺动脉高压:CT 征象的预后意义。
AJR Am J Roentgenol. 2011 Jun;196(6):1300-4. doi: 10.2214/AJR.10.5221.
3
Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症患者的死亡风险和死亡原因。
Respir Res. 2019 Dec 3;20(1):271. doi: 10.1186/s12931-019-1243-3.
4
Emphysema is an independent risk factor for 5-year mortality in patients with bronchiectasis.肺气肿是支气管扩张症患者5年死亡率的独立危险因素。
Clin Respir J. 2017 Nov;11(6):887-894. doi: 10.1111/crj.12432. Epub 2016 Jan 11.
5
The development of bronchiectasis on chest computed tomography in children with cystic fibrosis: can pre-stages be identified?囊性纤维化患儿胸部计算机断层扫描中支气管扩张的发展:能否识别前期阶段?
Eur Radiol. 2016 Dec;26(12):4563-4569. doi: 10.1007/s00330-016-4329-z. Epub 2016 Apr 23.
6
[Hemoptysis in adults with bronchiectasis: correlation with disease severity and exacerbation risk].[成人支气管扩张症咯血与疾病严重程度及加重风险的相关性]
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Jan 12;40(1):16-23. doi: 10.3760/cma.j.issn.1001-0939.2017.01.005.
7
Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis.阻塞性气道疾病对非囊性纤维化支气管扩张症患者的影响。
Ann Saudi Med. 2004 Jul-Aug;24(4):284-7. doi: 10.5144/0256-4947.2004.284.
8
Bronchiectasis-related amyloidosis as a cause of chronic renal failure.支气管扩张相关淀粉样变性作为慢性肾衰竭的一个病因
Ren Fail. 2002 Nov;24(6):815-23. doi: 10.1081/jdi-120015683.
9
Radiologic computed tomography features of Mycobacterium abscessus in cystic fibrosis.囊性纤维化患者脓肿分枝杆菌的放射计算机断层扫描特征
Clin Respir J. 2018 Feb;12(2):459-466. doi: 10.1111/crj.12536. Epub 2016 Aug 22.
10
Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation.晚期非囊性纤维化支气管扩张症与囊性纤维化患者在肺移植等待名单上的生存情况比较。
Lung. 2015 Dec;193(6):933-8. doi: 10.1007/s00408-015-9811-x. Epub 2015 Oct 1.

引用本文的文献

1
Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.芬兰支气管扩张症患者的死亡风险因素:一项为期四年的研究。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251358596. doi: 10.1177/14799731251358596. Epub 2025 Aug 17.
2
Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis.与支气管扩张症相关的真实世界疾病负担、死亡率及医疗资源利用情况。
Chron Respir Dis. 2025 Jan-Dec;22:14799731241310897. doi: 10.1177/14799731241310897.
3
Prevalence of bronchiectasis in adults: a meta-analysis.

本文引用的文献

1
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases.氧化 DNA 损伤与体细胞突变:与慢性炎症性气道疾病分子发病机制的关联。
Chest. 2012 May;141(5):1243-1250. doi: 10.1378/chest.11-1653. Epub 2011 Nov 23.
2
Observations on DRY BRONCHIECTASIS.干性支气管扩张症观察
Br Med J. 1933 Apr 8;1(3770):597-620.1. doi: 10.1136/bmj.1.3770.597.
3
Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.非囊性纤维化性支气管扩张症:21 世纪的诊断与管理。
成人支气管扩张症的患病率:一项荟萃分析。
BMC Public Health. 2024 Sep 30;24(1):2675. doi: 10.1186/s12889-024-19956-y.
4
Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study.慢性支气管炎气道细菌定植加重期的呼吸道病原体:一项队列研究。
Clin Respir J. 2024 Aug;18(8):e13811. doi: 10.1111/crj.13811.
5
Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.肺血管阻力可预测支气管扩张症相关肺动脉高压患者的死亡率。
J Hypertens. 2024 Oct 1;42(10):1703-1710. doi: 10.1097/HJH.0000000000003782. Epub 2024 Jun 10.
6
Health-Related Quality of Life and Stress-Related Disorders in Patients with Bronchiectasis after Pulmonary Resection.肺切除术后支气管扩张症患者的健康相关生活质量和应激相关障碍
J Pers Med. 2023 Aug 26;13(9):1310. doi: 10.3390/jpm13091310.
7
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中曲霉菌病的临床特征。
Infection. 2023 Aug;51(4):813-829. doi: 10.1007/s15010-022-01960-2. Epub 2023 Jan 20.
8
Functional impairment in bronchiectasis: Spirometry parameters versus St. George's Respiratory Questionnaire scores: Any co-relation?支气管扩张症的功能损害:肺量计参数与圣乔治呼吸问卷评分:有相关性吗?
Lung India. 2021 Nov-Dec;38(6):545-551. doi: 10.4103/lungindia.lungindia_707_20.
9
Infection prevention in general medical wards: A call to action.综合内科病房的感染预防:行动呼吁。
Afr J Thorac Crit Care Med. 2019 Dec 6;25(4). doi: 10.7196/AJTCCM.2019.v25i4.036. eCollection 2019.
10
Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities.非囊性纤维化支气管扩张症伴呼吸合并症患者的死亡率增加。
Sci Rep. 2021 Mar 29;11(1):7126. doi: 10.1038/s41598-021-86407-8.
Postgrad Med J. 2010 Aug;86(1018):493-501. doi: 10.1136/pgmj.2009.091041.
4
Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa.雾化多粘菌素对铜绿假单胞菌定植的非囊性纤维化支气管扩张症患者的疗效。
Thorax. 2010 Jun;65(6):553. doi: 10.1136/thx.2008.112284.
5
Bronchiectasis: an update.支气管扩张症:最新进展
Clin Respir J. 2009 Jul;3(3):126-34. doi: 10.1111/j.1752-699X.2009.00131.x.
6
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗工作组,得到国际心肺移植学会(ISHLT)认可。
Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27.
7
Assessment of chest high-field magnetic resonance imaging in children and young adults with noncystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with pulmonary function.非囊性纤维化慢性肺病儿童和青年的胸部高场磁共振成像评估:与高分辨率计算机断层扫描的比较及与肺功能的相关性
Invest Radiol. 2009 Sep;44(9):532-8. doi: 10.1097/RLI.0b013e3181b4c1ba.
8
Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis.痰液颜色:非囊性纤维化支气管扩张症中的一种有用临床工具。
Eur Respir J. 2009 Aug;34(2):361-4. doi: 10.1183/09031936.00163208.
9
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival.支气管扩张症的死亡率:一项评估影响生存因素的长期研究。
Eur Respir J. 2009 Oct;34(4):843-9. doi: 10.1183/09031936.00003709. Epub 2009 Apr 8.
10
Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis.支气管扩张症成人中性粒细胞氧化爆发减弱时的杀菌活性
APMIS. 2009 Feb;117(2):133-9. doi: 10.1111/j.1600-0463.2008.00028.x.